Evaluation of high resolution melting technique for detection of JAK2-V617F mutation in formalin-fixed paraffin-embedded specimen from myeloproliferative neoplasm cases
Introduction: Myeloproliferative neoplasm (MPN) is a group of myeloid disorders which leads to erythrocytosis, thrombocytosis and leucocytosis. MPN with BCR-ABL positive is chronic myeloid leukaemia (CML) while BCR-ABL negative MPN includes polycythaemia Vera (PV), essential thrombocytemia (ET) an...
Saved in:
Main Authors: | Abdullahi, Mohammad Reza, Abdullah, Nor Zamzila, Ismail, Rosmawati, Muhammad, Siti Aeshah @ Naznin, A.Talib, Norlelawati |
---|---|
Format: | Article |
Language: | English English |
Published: |
Kulliyyah (Faculty) of Medicine, International Islamic University Malaysia
2019
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/76120/1/76120_Evaluation%20of%20high%20resolution%20melting%20technique%20for%20detection%20of%20JAK2-V617F%20mutation%20in%20formalin-fixed%20paraffin-embedded%20specimen%20from%20myeloproliferative%20neoplasm%20cases.pdf http://irep.iium.edu.my/76120/2/76120_Evaluation%20of%20high%20resolution%20melting%20technique%20for%20detection%20of%20JAK2-V617F%20mutation%20in%20formalin-fixed%20paraffin-embedded%20specimen%20from%20myeloproliferative%20neoplasm%20case_SCOPUS.pdf http://irep.iium.edu.my/76120/ http://iiumedic.net/imjm/v1/download/volume_18_no_2/Pages-from-IMJMVol18No2-15.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concomitant BCR-ABL and JAK2 V617F in a patient with myeloproliferative neoplasm: a case report
by: A, Alia Suzana, et al.
Published: (2023) -
Gene aberrations and methylation analysis of JAK/stat and toll-like receptor downstream signalling in BCR-ABL-negative myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms overlap syndromes
by: Cai, Chia Yuh
Published: (2021) -
FLT3 and NPM1 mutations in patients with Myeloid neoplasms
by: Mansoor, Mohammad Naem, et al.
Published: (2021) -
Suppressor of cytokine signaling 3 is down-regulated by BCR-ABL and results in loss of JAK2 V617F in a patient with concurrent BCR-ABL translocation and JAK2 V617F mutation
by: Ang, C.H., et al.
Published: (2010) -
Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next generation sequencing panel
by: Tan, Jaymi
Published: (2021)